Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CLEVELAND, Dec. 15, 2023 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq:ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
Related news for (ABEO)
- Abeona Therapeutics® Appoints James A. Gow, MD, MBA, MS, MHCM, as Senior Vice President, Head of Clinical Development & Medical Affairs
- Abeona Therapeutics® Reports Second Quarter 2025 Financial Results and Corporate Updates
- 24/7 Market News Snapshot 14 August, 2025 – Abeona Therapeutics Inc. Common Stock (NASDAQ:ABEO)
- Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Abeona Therapeutics® to Present at the Jefferies Global Healthcare Conference
